908 Devices Expands Scientific Advisory Board, Creates Dedicated Proteomics PanelBusiness Wire • 08/02/21
908 Devices Expands Strategic Distribution Network in APAC, Europe, and the AmericasBusiness Wire • 07/28/21
908 Devices and Transcenta's Joint Innovation Partnership Accelerates Biopharma DevelopmentBusiness Wire • 07/22/21
908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data InsightsBusiness Wire • 06/22/21
908 Devices Appoints Marcia Eisenberg, Ph.D., Chief Scientific Officer of Labcorp Diagnostics, to its Board of DirectorsBusiness Wire • 06/08/21
908 Devices Inc. (MASS) CEO Kevin Knopp on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
908 Devices Reports First Quarter 2021 Financial Results and Reiterates 2021 Revenue OutlookGlobeNewsWire • 05/13/21
908 Devices Increases Focus on Biotherapeutics with Expansion of Scientific Advisory BoardBusiness Wire • 05/07/21
908 Devices to Report First Quarter Financial Results on May 13, 2021 and Host 2021 Annual Meeting of Stockholders on June 17, 2021GlobeNewsWire • 04/14/21
908 Devices Provides Handheld Mass Spec for Trace Detection to U.S. Border PatrolBusiness Wire • 04/08/21
908 Devices' (MASS) CEO Kevin Knopp on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/30/21
908 Devices Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Revenue OutlookGlobeNewsWire • 03/30/21
908 Devices to Report Fourth Quarter and Full Year 2020 Financial Results on March 30, 2021Business Wire • 02/22/21